secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001493152-26-004461
Event type: dividend
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio board to evaluate potential one-time special cash dividend after unspecified milestones
--------------------------------------------------------------------------------

- Board intends to evaluate a special cash dividend contingent on future financial milestones (revenue, earnings targets).
- No dividend has been declared; any declaration subject to financial performance, solvency laws, and board approval.
- No assurance can be given on timing, amount, or whether a dividend will occur at all.
- Company plans to provide further updates as appropriate under disclosure requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226004461/0001493152-26-004461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226004461/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer